Abstract
There has been little professional discussion about the implications of blastomere analysis for genetic screening. In this article, some of the legal, ethical, and practical issues associated with the technology are identified. Issues are categorized as those involving availability and payment, phenotype selection, and imperfect genes. Nurses need to be knowledgeable about these issues to participate in the formation of policies governing the use of blastomere analysis and other genetic screening procedures.